ArticleAlzheimer's research & therapy2025
Revealing heterogeneity in mild cognitive impairment based on individualized structural covariance network.
Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effects of dietary supplements on cognitive outcomes and physiological biomarkers in mild cognitive impairment: a systematic review and network meta-analysis.Frontiers in nutrition · 2026Pooled it
- A false discovery rate control method using a fully connected hidden Markov random field for neuroimaging data.Medical image analysis · 2026Article
- Magnetic Resonance Imaging-Based Cortical and Subcortical Volumetric Changes in Alzheimer's Disease: Association with Clinical Severity.Diagnostics (Basel, Switzerland) · 2026Article
- Data-driven glycolipid network phenotypes reveal a graded risk spectrum for cardiometabolic multimorbidity: a prospective study in middle-aged and older Chinese adults.Lipids in health and disease · 2026Article
- Retinal microvascular dysfunction in mild cognitive impairment: Associations with cerebral small vessel disease, plasma biomarkers, and cognitive decline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Distinguishing early from late mild cognitive impairment: a multi-level analysis of regional morphometry and KLS-derived network topology.Frontiers in aging neuroscience · 2026Article
- Analysis of comorbid characteristics, molecular mechanisms between mild cognitive impairment and Alzheimer's disease with interventions in a community-based population in Shanghai.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMild cognitive impairment (MCI) is a heterogeneous disorder with significant individual variabilities in clinical and biological features. Abnormal inter-regional structural covariance suggests disruption of the brain structural network in MCI. Most studies have examined group-level structural covariance alterations while ignoring individual-level differences. Hence, we aimed to investigate the heterogeneity of MCI using individual differential structural covariance network (IDSCN) analysis.
methodsT1-weighted images of 596 MCI patients and 309 cognitively normal (CN) were collected from the ADNI database as discovery dataset, and 122 MCI and 117 CN from the OASIS-3 dataset as validation cohort. We constructed each patient's IDSCN using regional gray matter volume and applied K-means clustering analysis to identify MCI subtypes based on significantly altered covariance edges. Then, clinical features, brain structure, and gene expression profiles were evaluated for each subtype.
resultsIn the ADNI dataset, MCI patients exhibited significant alterations in structural covariance edges, mainly involving the hippocampus, parahippocampal gyrus, and amygdala. Two robust MCI subtypes were identified. Subtype 1 showed faster disease progression relative to subtype 2, which was validated in the independent OASIS-3 dataset. Significant differences between two subtypes were found in clinical cognition and biomarkers, cerebral atrophy patterns, and enriched genes for metal ion transport and neuron projection development. Finally, correlation analysis and functional annotation further revealed that the affected edges were related to cognitive performance and implicated in memory and emotion terms.
conclusionsIn summary, these findings offer new perspectives into understanding the heterogeneity of MCI and facilitate strategies for future precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.